Literature DB >> 3033179

Effect of converting enzyme inhibitors on hypertensive large arteries in humans.

M E Safar, S L Laurent, J D Bouthier, G M London, A R Mimran.   

Abstract

As demonstrated in hypertensive humans on the basis of non-invasive Doppler methods, converting enzyme inhibitors (CEI) dilate not only small arteries but also large arteries, particularly in the brachial and the carotid circulations. The dilating effect of CEI on large arteries is associated with an enhancement of systemic and brachial arterial compliance, implying a particular action of the drug on arterial smooth muscle. Converting enzyme inhibitors are thus able to reverse the reduced arterial compliance observed in patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3033179

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  7 in total

1.  Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.

Authors:  B E Pannier; V G Garabedian; O Madonna; M Fouchard; B Darne; M E Safar
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

2.  Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers. off.

Authors:  P Demolis; S Chalon; D Annane; P Duhaze; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

3.  Comparison of lisinopril and nitrendipine on the pulsatility index in mild essential arterial hypertension.

Authors:  D Duprez; M De Buyzere; F Brusselmans; A Maas; D L Clement
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

Review 4.  Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy.

Authors:  C Morisco; L Argenziano; N Tozzi; A F Mele; B Ricciardelli; G Condorelli; B Trimarco
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 5.  Mechanical function and histological structure of the arterial wall. The response to antihypertensive treatment.

Authors:  M E Safar; B I Lévy
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 6.  Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.

Authors:  B Dahlöf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).

Authors:  Piero Ruggenenti; Ilian Iliev; Grazia Maria Costa; Aneliya Parvanova; Annalisa Perna; Giovanni Antonio Giuliano; Nicola Motterlini; Bogdan Ene-Iordache; Giuseppe Remuzzi
Journal:  Diabetes Care       Date:  2008-04-28       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.